D
Daniel Virella
Researcher at Universidade Nova de Lisboa
Publications - 82
Citations - 952
Daniel Virella is an academic researcher from Universidade Nova de Lisboa. The author has contributed to research in topics: Medicine & Body mass index. The author has an hindex of 15, co-authored 76 publications receiving 722 citations.
Papers
More filters
Journal ArticleDOI
Development of The Viking Speech Scale to classify the speech of children with cerebral palsy
Lindsay Pennington,Daniel Virella,Tone R. Mjøen,Maria da Graça Andrada,Janice Murray,Allan Colver,Kate Himmelmann,Gija Rackauskaite,Andra Greitane,Audrone Prasauskiene,Guro L. Andersen,Javier De La Cruz +11 more
TL;DR: It is concluded that the Viking Speech Scale is a reliable tool to describe the speech performance of children with cerebral palsy, which can be applied through direct observation of children or through case note review.
Journal ArticleDOI
Nutritional risk assessment and cultural validation of the modified NUTRIC score in critically ill patients—A multicenter prospective cohort study
TL;DR: Almost half of the patients in Portuguese ICUs are at high nutritional risk, and NUTRIC score was strongly associated with main clinical outcomes, including mortality from all causes at 28 days after admission.
Journal ArticleDOI
Early high calcium and phosphorus intake by parenteral nutrition prevents short-term bone strength decline in preterm infants.
Luís Pereira-da-Silva,Ana Costa,Laura Pereira,Ana-Filipa Filipe,Daniel Virella,E Leal,Ana-Catarina Moreira,Maria Luiza Correa da Camara Rosa,Lino Mendes,Micaela Serelha +9 more
TL;DR: Early assigned parenteral intake of Ca 75 mg ·kg−1 · day−1 and P 44 mg · kg−1· day −1 significantly contributed to preventing short-term bone strength decline in preterm infants.
Journal ArticleDOI
Nutritional Assessment in Preterm Infants: A Practical Approach in the NICU.
TL;DR: A practical approach for nutritional assessment in preterm infants under intensive care, based on anthropometric measurements and commonly used biochemical markers, is suggested, which could be proxies of body composition but need validation.
Journal ArticleDOI
Use of palivizumab to control an outbreak of syncytial respiratory virus in a neonatal intensive care unit
TL;DR: The use of palivizumab might have contributed to arresting the outbreak of RSV infection in the NICU, suggesting that it could be an additional resource in the control of severe nosocomial RSV outbreaks.